A detailed history of Turning Point Benefit Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Turning Point Benefit Group, Inc. holds 529 shares of PFE stock, worth $13,267. This represents 0.01% of its overall portfolio holdings.

Number of Shares
529
Holding current value
$13,267
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$23.29 - $25.88 $12,320 - $13,690
529 New
529 $14.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Turning Point Benefit Group, Inc. Portfolio

Follow Turning Point Benefit Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Turning Point Benefit Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Turning Point Benefit Group, Inc. with notifications on news.